Search research articles
Contact Us
Filters
Showing results (1-10 of 117) with videos related to
Page
of 12
Sort By:
Therapeutic Advances in Gastroenterology
|
September 22, 2017
The global impact of IBS: time to think about IBS-specific models of care?
Maura Corsetti, Peter Whorwell
F1000Research
|
October 19, 2017
The management of functional dyspepsia in clinical practice: what lessons can be learnt from recent literature?
Maura Corsetti, Mark Fox
Expert Review of Gastroenterology & Hepatology
|
February 25, 2016
Novel pharmacological therapies for irritable bowel syndrome
Maura Corsetti, Peter Whorwell
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 8, 2015
Ghrelin Agonists as Emerging Prokinetic Agents
Jan Tack, Maura Corsetti
Expert Opinion on Pharmacotherapy
|
December 16, 2014
Naloxegol , a new drug for the treatment of opioid-induced constipation
Maura Corsetti, Jan Tack
Expert Opinion on Pharmacotherapy
|
August 2, 2002
Tegaserod: a new 5-HT(4) agonist in the treatment of irritable bowel syndrome
Maura Corsetti, Jan Tack
Neurogastroenterology and Motility
|
June 12, 2019
Rectal area as surrogate measure of rectal emptying during MR defecography
Guido Basilisco, Maura Corsetti
Expert Opinion on Drug Metabolism & Toxicology
|
September 19, 2012
Prucalopride: evaluation of the pharmacokinetics, pharmacodynamics, efficacy and safety in the treatment of chronic constipation
Jan Tack, Maura Corsetti
Neurogastroenterology and Motility
|
September 29, 2020
Seated anorectal manometry during simulated evacuation: A physiologic exercise or a new clinically useful diagnostic test?
Guido Basilisco, Maura Corsetti
Alimentary Pharmacology & Therapeutics
|
June 12, 2019
Letter: limitations of defecography among patients with refractory constipation
Guido Basilisco, Maura Corsetti
Page
of 12
Search research articles
Search
Showing results (1-10 of 117) with videos related to
Sort By:
Page
of 12
Therapeutic Advances in Gastroenterology
|
September 22, 2017
The global impact of IBS: time to think about IBS-specific models of care?
Maura Corsetti, Peter Whorwell
F1000Research
|
October 19, 2017
The management of functional dyspepsia in clinical practice: what lessons can be learnt from recent literature?
Maura Corsetti, Mark Fox
Expert Review of Gastroenterology & Hepatology
|
February 25, 2016
Novel pharmacological therapies for irritable bowel syndrome
Maura Corsetti, Peter Whorwell
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 8, 2015
Ghrelin Agonists as Emerging Prokinetic Agents
Jan Tack, Maura Corsetti
Expert Opinion on Pharmacotherapy
|
December 16, 2014
Naloxegol , a new drug for the treatment of opioid-induced constipation
Maura Corsetti, Jan Tack
Expert Opinion on Pharmacotherapy
|
August 2, 2002
Tegaserod: a new 5-HT(4) agonist in the treatment of irritable bowel syndrome
Maura Corsetti, Jan Tack
Neurogastroenterology and Motility
|
June 12, 2019
Rectal area as surrogate measure of rectal emptying during MR defecography
Guido Basilisco, Maura Corsetti
Expert Opinion on Drug Metabolism & Toxicology
|
September 19, 2012
Prucalopride: evaluation of the pharmacokinetics, pharmacodynamics, efficacy and safety in the treatment of chronic constipation
Jan Tack, Maura Corsetti
Neurogastroenterology and Motility
|
September 29, 2020
Seated anorectal manometry during simulated evacuation: A physiologic exercise or a new clinically useful diagnostic test?
Guido Basilisco, Maura Corsetti
Alimentary Pharmacology & Therapeutics
|
June 12, 2019
Letter: limitations of defecography among patients with refractory constipation
Guido Basilisco, Maura Corsetti
Page
of 12